GENERAL COUNSEL
Fri, Nov 15, 2024
Nov 15
exercised or converted securities in DAWN
3,687 shares @ $0.00
Decreased holdings by -7.70%
Net across this filing: +19.40% (+5,234 shares)
Option Exercise
Sale tied to a same-time option exercise
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology